Home

Designed for school students & undergraduate entrance aspirants preparing for board exams, NEET, JEE and more.

JEE (Mains & Adv)NEET (UG)CBSE BoardISC BoardUP BoardCUET

Built for graduates & professionals targeting competitive exams — UPSC, CAT, GMAT, GRE, IELTS, banking & more.

GREGMATCATUPSCIBPSIELTSTOEFLSATACT

Core school & undergraduate subjects aligned with CBSE, ISC, UP Board, NEET and JEE syllabi.

PracticeMock TestsResources
Back to Current Affairs
https://www.thehindu.com/news/cities/bangalore/fda-cancels-16-pharmacy-licences-suspends-8-including-pfizer-depot/article71488486.ece21 September 2026

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

Karnataka FSDA cancelled 16 pharmacy licences and suspended 8, including a Pfizer depot, as reported on 20 September 2026. The action reflects regulatory enforcement against pharmacies in the state.

Read original source

Why in News?

The news is in the spotlight because Karnataka's Food Safety and Drug Administration took decisive action by cancelling and suspending multiple pharmacy licences, notably involving a major pharmaceutical company's depot.

Context

The action was carried out by the Karnataka FSDA, the state authority responsible for overseeing drug and pharmacy regulations, and was reported by The Hindu on the specified date.

Background

The article reports the regulatory action taken by Karnataka FSDA against pharmacies; no further historical background is provided in the source.

Key Facts

• Karnataka FSDA cancelled 16 pharmacy licences. • Karnataka FSDA suspended 8 pharmacy licences. • Among the suspended licences is a Pfizer depot. • The report was published on 20 September 2026.

Analysis

The cancellations and suspensions indicate that Karnataka FSDA is actively enforcing compliance with pharmacy and drug safety regulations, signalling a strict regulatory stance to ensure quality and safety of medicines distributed in the state.

UPSC Takeaway

Aspirants should note that Karnataka FSDA cancelled 16 pharmacy licences and suspended 8, including a Pfizer depot, on 20 September 2026, reflecting stringent regulatory oversight of pharmacies in the state. Challenges: • The article does not specify the reasons behind the cancellations and suspensions. Way Forward: • The article does not mention any specific response or way forward following the action.

We Value Your Privacy

Edvaya uses cookies to enhance your learning experience, analyze platform usage, and provide personalized content. You can customize your preferences or accept all cookies to continue.

By continuing, you agree to our Cookie Policy and Privacy Policy